Previous studies have reported that the patients with early-stage laryngeal carcinoma exhibited a lower level of IL-17 mRNA expression than those with advanced stages, and cancer tissues exhibited a significantly higher level of IL-17 mRNA expression than pericarcinoma tissues [34, 35]. This evidence concerns the gene IL17A and cancer.